Brief: The9 To Invest In GenAI LLM Digital Precision Medicine Platform WM Therapeutic
26/03/2024 13:47
March 26 (Reuters) - The9 Ltd NCTY.O :
* THE9 SIGNED A DEFINITIVE SHARE PURCHASE AGREEMENT TO
INVEST IN
GENAI LLM DIGITAL PRECISION MEDICINE PLATFORM FOR BRAIN DISEASE
WM THERAPEUTIC
* THE9 WILL PAY CASH CONSIDERATION OF US$1.5 MILLION
Source text for Eikon: ID:nPn7GZwZxa
Further company coverage: NCTY.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on The9
See all newsBrief: The9 Investee Nanyang Biologics (Nyb) Advancing Planned Nasdaq Listing For The $1.5 Billion Business Combination
NASDAQ RESUMED AT 09:40 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:35 AM
Brief: The9 Establishes Joint Venture To Focus On Mobile Game Operation And Distribution In China's Sinking Market
Brief: Shanghai The9 Information Technology Signs JV Agreement With Shenzhen Jituo Interactive Technology